Xiaowen Yu

1.4k total citations
46 papers, 1.1k citations indexed

About

Xiaowen Yu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Xiaowen Yu has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 7 papers in Nephrology. Recurrent topics in Xiaowen Yu's work include Chronic Kidney Disease and Diabetes (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xiaowen Yu is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xiaowen Yu collaborates with scholars based in China, United States and Germany. Xiaowen Yu's co-authors include Zhanjun Jia, Songming Huang, Aihua Zhang, Yue Zhang, Guixia Ding, Man Xu, Xuejuan Zhang, Li Sun, Hua Hu and Shengtao Yuan and has published in prestigious journals such as Science Translational Medicine, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Xiaowen Yu

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowen Yu China 19 440 226 139 138 128 46 1.1k
Takafumi Nakao Japan 18 498 1.1× 214 0.9× 120 0.9× 114 0.8× 192 1.5× 59 1.3k
Marta Prieto Spain 20 409 0.9× 224 1.0× 80 0.6× 232 1.7× 201 1.6× 43 1.4k
Xia Zhong China 19 423 1.0× 104 0.5× 122 0.9× 158 1.1× 56 0.4× 42 1.1k
Ruizhi Tan China 21 716 1.6× 132 0.6× 179 1.3× 340 2.5× 89 0.7× 73 1.4k
Yan Shen China 16 343 0.8× 101 0.4× 176 1.3× 133 1.0× 171 1.3× 42 1.1k
He-He Hu China 11 554 1.3× 81 0.4× 128 0.9× 173 1.3× 112 0.9× 14 1.3k
Yu Jin Jung South Korea 19 434 1.0× 327 1.4× 78 0.6× 267 1.9× 198 1.5× 30 1.4k
Hui Lin China 22 642 1.5× 69 0.3× 179 1.3× 122 0.9× 139 1.1× 73 1.4k
Jing Xiong China 24 677 1.5× 187 0.8× 170 1.2× 303 2.2× 260 2.0× 92 1.6k

Countries citing papers authored by Xiaowen Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaowen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen Yu more than expected).

Fields of papers citing papers by Xiaowen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen Yu. The network helps show where Xiaowen Yu may publish in the future.

Co-authorship network of co-authors of Xiaowen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowen Yu. A scholar is included among the top collaborators of Xiaowen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowen Yu. Xiaowen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yue, Chenxi Guo, Xiaowen Yu, et al.. (2025). Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential. mBio. 16(3). e0322624–e0322624. 3 indexed citations
3.
4.
Liu, Qianqi, et al.. (2024). GDH1 exacerbates renal fibrosis by inhibiting the transcriptional activity of peroxisome proliferator‐activated receptor gamma. FEBS Journal. 291(20). 4581–4601. 1 indexed citations
5.
Huang, Songming, et al.. (2024). Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis. EMBO Molecular Medicine. 16(7). 1675–1703. 1 indexed citations
6.
Ye, Guanchen, et al.. (2024). Comparative evaluation of transverse width indices for diagnosing maxillary transverse deficiency. BMC Oral Health. 24(1). 808–808. 2 indexed citations
7.
Wei, Yanhong, et al.. (2024). Synthesis and function studies on formaldehyde adsorption of PEI-PU copolymers. Journal of Physics Conference Series. 2819(1). 12010–12010.
8.
Bai, Mi, Mengqiu Wu, Mingzhu Jiang, et al.. (2023). LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO Molecular Medicine. 15(2). e16581–e16581. 48 indexed citations
9.
10.
Chen, Xuan, et al.. (2021). Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome. Annals of Palliative Medicine. 10(8). 9223–9232. 2 indexed citations
11.
Xu, Man, Jiajia Wang, Songming Huang, et al.. (2021). Cilomilast Ameliorates Renal Tubulointerstitial Fibrosis by Inhibiting the TGF-β1-Smad2/3 Signaling Pathway. Frontiers in Medicine. 7. 626140–626140. 17 indexed citations
12.
Yu, Xiaowen, Jing Feng, Lu Huang, et al.. (2019). Molecular Basis Underlying Host Immunity Subversion by Mycobacterium tuberculosis PE/PPE Family Molecules. DNA and Cell Biology. 38(11). 1178–1187. 14 indexed citations
13.
Yu, Xiaowen, Dandan Wei, Hongzhi Du, et al.. (2019). Synergistic combination of DT‐13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC‐823 cells via NM IIA/EGFR/HK II axis. Journal of Cellular and Molecular Medicine. 23(10). 6622–6634. 13 indexed citations
14.
Yu, Xiaowen, Man Xu, Xuejuan Zhang, et al.. (2018). Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function. EBioMedicine. 36. 266–280. 152 indexed citations
15.
Yu, Xiaowen, Qingqing Yang, Sensen Lin, Shengtao Yuan, & Li Sun. (2017). Synergistic combination of YS-1 and adriamycin inhibits human renal cancer through ERK1/2 signaling pathway in vitro and in vivo. Oncology Reports. 37(3). 1756–1764. 1 indexed citations
16.
Chen, Xuan, Brian Xi, Xiaowen Yu, et al.. (2017). SNP rs3202538 in 3′UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population. Cancer Cell International. 17(1). 81–81. 11 indexed citations
17.
Du, Hongzhi, Yang Liu, Xudong Chen, et al.. (2017). DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo. European Journal of Pharmacology. 818. 124–131. 20 indexed citations
18.
Du, Hongzhi, Yue Huang, Xiaowen Yu, et al.. (2016). DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment. Oncology Reports. 36(2). 721–728. 21 indexed citations
19.
Yu, Xiaowen, Renping Zhao, Sensen Lin, et al.. (2015). CXCL16 induces angiogenesis in autocrine signaling pathway involving hypoxia-inducible factor 1α in human umbilical vein endothelial cells. Oncology Reports. 35(3). 1557–1565. 45 indexed citations
20.
Owens, Gregory P., Don Gilden, M P Burgoon, Xiaowen Yu, & Jeffrey L. Bennett. (2011). Viruses and Multiple Sclerosis. The Neuroscientist. 17(6). 659–676. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takafumi Nakao Breakdown of academic impact, for papers by Marta Prieto Breakdown of academic impact, for papers by Xia Zhong Breakdown of academic impact, for papers by Ruizhi Tan Breakdown of academic impact, for papers by Yan Shen Breakdown of academic impact, for papers by He-He Hu Breakdown of academic impact, for papers by Yu Jin Jung Breakdown of academic impact, for papers by Hui Lin Breakdown of academic impact, for papers by Jing Xiong
Rankless by CCL
2026